These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32943326)

  • 1. Early liver metastases after "failure" of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy?
    Boerner T; Zambirinis C; Gagnière J; Chou JF; Gonen M; Kemeny NE; Cercek A; Connell LC; Kingham TP; Allen PJ; Balachandran VP; Drebin J; Jarnagin WR; D'Angelica MI
    HPB (Oxford); 2021 Apr; 23(4):601-608. PubMed ID: 32943326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
    Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN
    Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases.
    Nishioka Y; Moriyama J; Matoba S; Kuroyanagi H; Hashimoto M; Shindoh J
    Dig Surg; 2018; 35(3):187-195. PubMed ID: 28848205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC).
    Gawdi R; Valenzuela CD; Moaven O; Stauffer JA; Del Piccolo NR; Cheung T; Corvera CU; Wisneski AD; Cha C; Russell G; Zarandi N; Dourado J; Shen P
    J Surg Oncol; 2022 Aug; 126(2):339-347. PubMed ID: 35429409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
    Satake H; Hashida H; Tanioka H; Miyake Y; Yoshioka S; Watanabe T; Matsuura M; Kyogoku T; Inukai M; Kotake T; Okita Y; Matsumoto T; Yasui H; Kotaka M; Kato T; Kaihara S; Tsuji A
    Oncologist; 2021 Jul; 26(7):e1125-e1132. PubMed ID: 33977607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases.
    Buisman FE; Galjart B; van der Stok EP; Kemeny NE; Balachandran VP; Boerner T; Cercek A; Grünhagen DJ; Jarnagin WR; Kingham TP; Verhoef C; Koerkamp BG; D'Angelica MI
    HPB (Oxford); 2020 Sep; 22(9):1271-1279. PubMed ID: 31889627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
    Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
    Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Chemotherapy with or without Hepatic Arterial Infusion Chemotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Oligometastasis: A Propensity Score-Matched Analysis.
    Li Z; Xu R; Chang X; Sun P
    J Vasc Interv Radiol; 2024 Mar; 35(3):416-427.e17. PubMed ID: 38008375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver-related mortality.
    Srouji R; Narayan R; Boerner T; Buisman F; Seier K; Gonen M; Balachandran VP; Drebin J; Jarnagin WR; Kingham TP; Wei A; Kemeny NE; D'Angelica M
    J Surg Oncol; 2020 Jun; 121(8):1314-1319. PubMed ID: 32236970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prediction of treatment outcome after adjuvant loco-regional chemotherapy following liver resection for colorectal metastases--preliminary results].
    Strnad R; Ryska M; Belina F; Langer D; Novotný J; Ludvíková M
    Rozhl Chir; 2006 Mar; 85(3):124-8. PubMed ID: 16689143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastases.
    Srouji RM; Narayan RR; Boerner T; Buisman FE; Seier K; Gonen M; Balachandran VP; Drebin JA; Jarnagin WR; Kingham TP; Wei A; Kemeny NE; D'Angelica MI
    J Surg Oncol; 2020 Dec; 122(8):1536-1542. PubMed ID: 32976666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
    House MG; Kemeny NE; Gönen M; Fong Y; Allen PJ; Paty PB; DeMatteo RP; Blumgart LH; Jarnagin WR; D'Angelica MI
    Ann Surg; 2011 Dec; 254(6):851-6. PubMed ID: 21975318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases.
    Devaud N; Kanji ZS; Dhani N; Grant RC; Shoushtari H; Serrano PE; Nanji S; Greig PD; McGilvray I; Moulton CA; Wei A; Gallinger S; Cleary SP
    HPB (Oxford); 2014 May; 16(5):475-80. PubMed ID: 23927606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases.
    Pulitanò C; Arru M; Catena M; Guzzetti E; Vitali G; Ronzoni M; Venturini M; Villa E; Ferla G; Aldrighetti L
    Ann Surg Oncol; 2008 Jun; 15(6):1661-9. PubMed ID: 18373123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy.
    Buisman FE; Filipe WF; Kemeny NE; Narayan RR; Srouji RM; Balachandran VP; Boerner T; Drebin JA; Jarnagin WR; Kingham TP; Wei AC; Grünhagen DJ; Verhoef C; Koerkamp BG; D'Angelica MI
    Ann Surg Oncol; 2021 Feb; 28(2):808-816. PubMed ID: 32648182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is complete liver resection without resection of synchronous lung metastases justified?
    Mise Y; Kopetz S; Mehran RJ; Aloia TA; Conrad C; Brudvik KW; Taggart MW; Vauthey JN
    Ann Surg Oncol; 2015 May; 22(5):1585-92. PubMed ID: 25373535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy.
    Narayan RR; Datta J; Goldman DA; Aveson VG; Walch HS; Sanchez-Vega F; Gönen M; Balachandran VP; Drebin JA; Jarnagin WR; Kingham TP; Wei AC; Schultz N; Kemeny NE; D'Angelica MI
    Ann Surg Oncol; 2022 Nov; 29(12):7579-7588. PubMed ID: 35896920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients.
    Gholami S; Stewart S; Kemeny N; Gönen M; Groot Koerkamp B; Cercek A; Kingham P; Balachandran V; Allen P; DeMatteo R; Wei A; Connell L; Drebin J; Jarnagin W; D'Angelica M
    Ann Surg Oncol; 2021 Jul; 28(7):3685-3694. PubMed ID: 33230748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.